Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1/2Taking peopleSMP-3124LP in Adults With Advanced Solid Tumors
- Where
- Celebration, Chicago, Columbus, Denver, Houston, Los Angeles, Nashville, San Francisco, Seattle
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT06526819 - Phase 1Not yet taking people in United StatesMTX-531-001 Phase 1 Study in Advanced Solid Tumors
- Where
- Newport Beach
- Age
- 18 years and over
- People
- 71
- Run by
- MEKanistic Therapeutics, Inc.
See details and how to joinNCT07874880 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Aurora, Charleston, Chicago, Cleveland, Denver, Duarte, Durham, Fairfax, Grand Rapids, Greenville, Houston, Nashville, New York, Providence, San Antonio, San Francisco, Sarasota, St Louis
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Phase 2Taking peopleConcurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Where
- Lexington
- Age
- 18 years to 99 years
- People
- 35
- Run by
- Mark Bernard
See details and how to joinNCT07770100 - Phase 1/2Taking peoplePhase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Where
- Boston, Fairfax, Houston, Huntersville, New Haven, Newport Beach, San Antonio, San Francisco, Seattle
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Ensem Therapeutics
See details and how to joinNCT06993844 - Phase 2Taking peopleSparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 98
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07278557 - Phase 4Taking peopleMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Where
- Portland
- Age
- 18 years and over
- People
- 160
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07405086 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - Phase 2Taking peopleA Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
- Where
- Baton Rouge, Fort Myers, Orlando, Roanoke, St. Petersburg, Tyler, West Palm Beach
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT07807163 · EU 2026-526741-10-00 - Phase 2Taking peopleShortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 42
- Run by
- University of Utah
See details and how to joinNCT07044635 - No phaseTaking peopleA Study of a New PET Scanner in People With Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 90
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07690917 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Fairfax, Grand Rapids, Houston, Pittsburgh, San Antonio, St Louis
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 3Taking peopleA Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
- Where
- Austin, Baltimore, Boston, Canton, Charleston, Charlottesville, Chicago, Cleveland, Colorado Springs, Columbus, Dallas, Detroit, Duarte, Greenville, Huntsville, Iowa City, Knoxville, Los Angeles, Louisville, Nashville, Newark, Newhaven, New York, Omaha, Orlando, Palo Alto, Philadelphia, Rochester, San Diego, San Francisco, Seattle, St Louis, Tampa, Tucson, Vancouver
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- Corbus Pharmaceuticals Inc.
See details and how to joinNCT07768189 · EU 2026-527123-94-00 - No phaseTaking peopleDynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- Where
- Houston
- Age
- 18 years and over
- People
- 1,400
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03145077 - Phase 2Taking peopleCCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 90
- Run by
- Washington University School of Medicine
See details and how to joinNCT07659678 - No phaseTaking peopleBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 471
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03010150 - Phase 1Taking peopleTrial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 11
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03114462 - Phase 2Taking peopleWeb-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
- Where
- Fort Worth, Houston
- Age
- 18 years and over
- People
- 300
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04003051 - Phase 1Taking peopleStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Where
- Boston, Charleston, Charlotte, Cleveland, Houston, La Jolla, Los Angeles, Nashville, New York, Pittsburgh, Providence, Sacramento, Tampa
- Age
- 18 years and over
- People
- 473 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT04429542 - Phase 1Taking peopleIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 54
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05039801 - No phaseTaking peoplePreventing Lymphedema in Patients Undergoing Surgical Treatment for Head and Neck Cancer Through Vein Reconstruction
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 37
- Run by
- University of Pittsburgh
See details and how to joinNCT07694726 - No phaseNot yet taking people in United StatesResistance Training and Creatine Supplementation for Head and Neck Cancer
- Where
- Charleston
- Age
- 18 years and over
- People
- 30
- Run by
- Medical University of South Carolina
See details and how to joinNCT07838090 - Phase 2Enrolling by invitationCombined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
- Where
- Ann Arbor, Charleston, Danville, Detroit, Farmington Hills, Irvine, Mattoon, Normal, Omaha, Orange, Tucson, Urbana
- Age
- 18 years and over
- People
- 50
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT07062354 - Phase 1Taking peoplePhase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
- Where
- Houston
- Age
- 18 years and over
- People
- 33
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07101432